Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 250

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 250
---
 shares of Enfusion Common Stock that ISP V                                                                                                                                                                         
 Main Fund EF LLC (“ISP V EF”) has the right to acquire upon the exchange of Common Units directly held by ISP V EF, (3) 538,887 shares of Enfusion Common Stock directly held by ICONIQ Strategic Partners V, L.P. (“ICONIQ                                                                                                      
 V”) and (4) 722,707 shares of Enfusion Common Stock directly held by ICONIQ Strategic Partners V-B, L.P. (“ICONIQ V-B”). ICONIQ V is the sole                                                                                                                                                                                    
 managing member of ISP V EF. ICONIQ Strategic Partners V GP, L.P. (“ICONIQ V GP”) is the sole general partner of each of ISP V-B EF, ICONIQ V, and ICONIQ                                                                                                                                                                        
 V-B. ICONIQ Strategic Partners V TT GP Ltd. (“ICONIQ V Parent GP” and, together with ISP V-B EF, ISP V EF, ICONIQ V, ICONIQ V-B, and ICONIQ V GP, the “ICONIQ Entities”) is the sole general partner of ICONIQ V GP. Divesh Makan, William J.G. Griffith, and Matthew Jacobson are the sole equity holders of ICONIQ V Parent GP 
 and may be deemed to beneficially own the shares held by the ICONIQ Entities. The address for each of the ICONIQ Entities is 50 Beale St., Ste. 2300, San Francisco, CA 94105.                                                                                                                                                   |

| (14) | Based solely on information provided in a Schedule 13G/A filed with the SEC on September 6, 2024. Consists                                                                                                                    
 of 7,873,643 shares of Enfusion Common Stock owned by various investment advisory clients of Brown Capital Management, LLC (“Brown Capital Adviser”), which may be deemed to be a beneficial owner of those shares due to its 
 discretionary power to make investment decisions over such shares for its clients and/or its ability to vote such shares. The address for Brown Capital Adviser is 1201 N. Calvert Street, Baltimore, MD 21202.               |

178

APPRAISAL RIGHTS OF ENFUSION STOCKHOLDERS General.Holders of Enfusion Common Stock will be entitled to appraisal rights under Section 262 of the DGCL in connection with the Merger. If you hold one or more shares of Enfusion Common Stock, you are entitled to appraisal rights under Delaware law and have the right to have your shares appraised by the Delaware Court of